Mereo BioPharma Group plc (MREO)

NASDAQ: MREO · IEX Real-Time Price · USD

2.740

-0.070 (-2.49%)

At close: Apr 26, 2024, 4:00 PM

2.750

+0.010 (0.36%)

After-hours: Apr 26, 2024, 4:11 PM EDT

Mereo BioPharma Group Cash Flow Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-29.47	-42.22	15.91	-204.54	-43.56	-40.04	-48.5	-35.49
Depreciation & Amortization	1.06	0.89	0.8	2	1.97	0.05	0.05	0.04
Share-Based Compensation	4.92	4.77	4.13	1.95	2.05	2.74	4.57	8.12
Other Operating Activities	2.35	-12.26	-27.39	165.16	-17.88	8.33	3.7	-9.75
Operating Cash Flow	-21.13	-48.82	-6.55	-35.43	-57.41	-28.92	-40.19	-37.08
Capital Expenditures	0	-0.01	-0.67	-0.02	-0.03	-0.04	-0.02	-0
Acquisitions	0	0	0	-0.44	12.59	0	0	0
Change in Investments	0	0	0	0	41.08	0	-3.13	0
Other Investing Activities	-0.42	2	0.14	2.33	0.47	0.36	-1.54	0.47
Investing Cash Flow	-0.42	1.99	-0.53	1.87	54.12	0.32	-4.68	0.47
Share Issuance / Repurchase	11.09	0	97.93	23.54	-2.2	-0.05	18.75	84.86
Debt Issued / Paid	-3.22	0	-0.87	19.89	-4.94	-2.64	24.34	4.33
Other Financing Activities	0.1	0.2	-	-	-	0.1	-0.91	-3.74
Financing Cash Flow	7.97	0.2	97.07	43.42	-7.14	-2.59	42.18	85.45
Exchange Rate Effect	2.82	-12.58	-1.46	-0.96	-0.44	-0.05	-1.73	2.83
Net Cash Flow	-13.58	-46.63	89.99	9.86	-10.43	-31.2	-2.69	48.83
Free Cash Flow	-21.13	-48.83	-7.22	-35.45	-57.44	-28.97	-40.21	-37.08
Free Cash Flow Margin	-211.32%	-	-15.83%	-	-	-	-	-
Free Cash Flow Per Share	-0.16	-0.41	-0.07	-0.52	-4.04	-1.67	-2.31	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).